Identification of the novel HLA-DPA1*01:49 allele by next-generation sequencing.

Alleles Exons / genetics HLA-DP alpha-Chains / genetics High-Throughput Nucleotide Sequencing Humans
HLA, HLA-DPA1*01:49 human leukocyte antigen next-generation sequencing novel allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
09 2021
Historique:
received: 10 02 2021
accepted: 09 03 2021
pubmed: 13 3 2021
medline: 12 10 2021
entrez: 12 3 2021
Statut: ppublish

Résumé

HLA-DPA1*01:49 differs from DPA1*01:03:01:04 by one nucleotide substitution in codon 119 in exon 3.

Identifiants

DOI: 10.1111/tan.14255 PMID: 33709616
pubmed: 33709616
doi: 10.1111/tan.14255
doi:

Substances chimiques

HLA-DP alpha-Chains 0
HLA-DPA1 antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-252

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Charlène Bouthemy (C)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.
ORCID: 0000-0002-0926-0445

Marine Cargou (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
ORCID: 0000-0002-1141-1417

Gwendaline Guidicelli (G)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Marylise Fort (M)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.

Nicolas Congy-Jolivet (N)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Identification of the novel HLA-DPA1*01:49...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Identification of the novel HLA-DPA1*01:49...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-D › Antigènes HLA-DP › Chaines alpha des antigènes HLA-DP › Identification of the novel HLA-DPA1*01:49...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Identification of the novel HLA-DPA1*01:49...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of the novel HLA-DPA1*01:49...